A genetically engineered herpes simplex virus, when combined with immunotherapy, reduces or eliminates tumors in one-third of clinical trial patients.
Cancer treatments are saving and extending more lives than ever. USC practitioners are guiding patients from diagnosis to treatment to facing their post-care future by connecting them with necessary resources.
High doses of corticosteroids, prescribed to manage cancer-related symptoms or treatment side effects, are the most significant factor in why some immunotherapies don’t work.
USC-led research finds that an electric field device placed on the scalp, along with immunotherapy and chemotherapy, may help patients with glioblastoma live longer.
Research uncovers a mechanism that protects the genome by avoiding catastrophic errors when repairing breaks in tightly packed DNA, a finding with implications for cancer and aging.
The radiation oncology and imaging center is the first in Orange County to offer biology-guided radiation therapy, which sends up-to-the-minute “signals” locating cancer cells in the body.
A USC-licensed startup biomedical company and a Keck Medicine of USC neurosurgeon focused on treating brain cancer are taking their invention public. Such collaborations are an important way for researchers to bring promising treatments to patients.
A USC-led study uses artificial intelligence to analyze genetic mutations and improve cancer treatment strategies.
The treatment would be the first gene therapy for glioblastoma to use a novel, more precise delivery system that is less likely to harm non-cancerous cells.
USC researchers found an association between levels of PFAS in drinking water and the incidence of certain digestive, endocrine, respiratory, and mouth and throat cancers.
